News

Published on 30 May 2024 on Zacks via Yahoo Finance

Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?


Article preview image

A month has gone by since the last earnings report for Incyte (INCY). Shares have added about 7.5% in that time frame, outperforming the S&P 500.

Will the recent positive trend continue leading up to its next earnings release, or is Incyte due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.

Incyte Q1 Earnings & Revenues Fall Shy of Estimates

NYSE.NVS price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Exploring Swiss Dividend Stocks In May 2024

Amidst a backdrop of fluctuating market conditions, the Swiss market demonstrated resilience, clo...

Simply Wall St. via Yahoo Finance 31 May 2024

Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Incyte (INCY). Shares have added about 7.5...

Zacks via Yahoo Finance 30 May 2024

Exploring Three Japanese Growth Companies With High Insider Ownership On The Tokyo Stock Exchange

Amid a backdrop of fluctuating global markets, with Japan's Nikkei 225 experiencing slight declin...

Simply Wall St. via Yahoo Finance 30 May 2024

Goldman Sachs initiates cover on six European pharma stocks

Goldman Sachs initiates cover on six European pharma stocks

Investing.com 30 May 2024

Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com

On Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed a...

Investing.com 30 May 2024

Three Leading Swiss Dividend Stocks With Yields Up To 6.1%

Swiss stocks experienced a downturn on Tuesday, influenced by global economic concerns including ...

Simply Wall St. via Yahoo Finance 30 May 2024

Goldman Sachs Says Buy European Pharma Stocks Touting Innovation

(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have ...

Bloomberg via Yahoo Finance 30 May 2024

Is Vanguard International Dividend Appreciation ETF (VIGI) a Strong ETF Right Now?

Designed to provide broad exposure to the World ETFs category of the market, the Vanguard Interna...

Zacks via Yahoo Finance 27 May 2024

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...

U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...

Benzinga via AOL 24 May 2024

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn’t one of t...

Insider Monkey via Yahoo Finance 24 Apr 2024